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Abstract
Persistent high-risk human papillomavirus (HR-HPV) infection is associated with anogenital and head & neck 
squamous epithelial (HNSCC) tumors, which altogether cause about 550,000 new cases every year. Several 
evidences suggest that the microbiota could have a role on the inflammatory, epithelial mesenchymal transition 
and tumorigenesis processes promoted by HR-HPV infection, yet the mechanisms involved remain to be clarified. 
In this review we report the state of the art on this topic and on the most promising in vitro  developed models 
for studying the host-pathogen interactions. Using MEDLINE, several terms were searched and combined to 
select the most pertinent papers. The investigation was limited to the international indexed articles published 
in PubMed in the last 10 years. This review reports the latest knowledge in the field of the microbial-associated 
anogenital tumors and HNSCC. In addition, we also discuss the in vitro  epithelial culture systems that reproduce 
the pathophysiological features of the tumoral microenvironment and the in vivo  response to microbial agents, 
thus representing a useful tool for analyzing at cellular and molecular levels the role played by infective agents in 
tumorigenesis.  
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INTRODUCTION
As referred in the last human papillomavirus (HPV) cancer report of the HPV Information Centre[1], 
unremitting HPV infection, mainly promoted by high-risk HPV (HR-HPV) 16 and 18 E6 and E7 
oncoproteins, is the main microbial etiological factor till now recognized that is necessary, yet not 
sufficient, for the development of anogenital and of head & neck cancers (namely of the tonsil, tongue and 
oropharynx).
Despite the progresses in vaccination and screening prevention led to the reduction of cases number[2,3], 
these tumors are still diffuse among the general population, with the highest mortality rate in countries 
with a low socio-economic level[3].
Cervical cancer is the 3rd most frequent female tumor in the world (2nd in the age range 15-44) with about 
600,000 new cases/year and a 50% mortality rate[4,5].
In the last three decades oropharyngeal tumors, which include some 450,000 new cases/year (mostly 
affecting older tobacco and alcohol users worldwide), have increased also in young people, due to sexual 
habits changes predisposing to HR-HPV infection[6]. 
It has been reported that oncogenic HPV-related oropharyngeal tumors have a better prognosis than 
those HPV negative[7,8]. On the other hand, it is known that HR-HPV-mediated cervical oncogenesis 
generally develops after a long latency (about 10-30 years from infection). Thus, it remains a conundrum 
the fact that tumor latency and prognosis differ in the two populations of patients, regardless of the 
treatment and of the fact that both types of cancer share a common infective cause[9]. Seemingly, HR-HPV 
infection is not per se enough to cause these cancers, though viruses are classified as Class 1 carcinogens 
by the International Agency for Research on Cancer[4]. Recent evidences suggest that the microbiota of 
the cervical and oropharyngeal niches (that includes bacteria, protozoa, viruses and fungi, although 
sometimes the term specifically refers only to bacterial communities) can have both a harmful and a 
protective role. Further, the microbiota can influence persistent HPV-mediated inflammation, epithelial 
mesenchymal transition (EMT) and tumorigenesis, although the mechanisms involved are still largely 
unknown and controversial[10]. In fact, just as a balanced bacteriota may be constituted by both pathogens 
and commensals, the human virota can include, among the others, both low risk and HR-HPVs, without 
inducing morbidity for its host if the immune surveillance and the whole microbiota itself are able to 
control its load and persistence[11]. 
Therefore, an open question is if commensal HPV types, belonging to the human virota, play a protective 
role against the oncogenic ones or not[12-15]. What is sure is that cancer often arises from a metabolic 
imbalance. Given this assumption, the metabolic profile of the microenvironment, in which host cells 
directly cooperate with viruses and bacteria, could reveal a snapshot of their functional and complex 
interactions that are at the basis of HPV infection, persistence susceptibility, inf lammation, EMT, 
uncontrolled cell proliferation and cancer progression.
To learn more about it, researchers have developed several in vitro co-culture systems that could mimic the 
physiological appearance of the tumoral microenvironment[16]. 
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On this basis, the purpose of this study was to show the state of the art on epithelial carcinogenesis and on 
the most suitable in vitro 3D models till now developed for the study of host-pathogens interactions.
By using MEDLINE, terms such as “microbiota”, “virota”, “virus”, “epitheliotropic virus”, “HPV”, 
“bacteriota”, “bacteria”, “Fusobacterium nucleatum”, “Porphyromonas gingivalis”, “EMT”, “eukaryotic cells”, 
“keratinocytes”, “epithelial cells” “epithelial infection”, “epithelial cancer”, “anogenital cancer”, “head and 
neck squamous cell carcinoma (HNSCC)”, “epithelial models”, “2D”, “3D”, “3D epithelial cultures”, “rafts”, 
“spheroids”, “reconstructed tissues”, both in single and mutually combined, were searched in titles and 
abstracts in order to find PubMed indexed most pertinent articles; only original research articles published 
in peer review journal were considered. Papers including EBV or other epitheliotropic viruses other than 
HPV were excluded.
The literature search was limited to the most recent scientific publications (10 years); six thousand and five 
hundred nine appropriate abstracts and full papers were carefully read and reviewed; those relevant (216) 
were reconsidered based on the above described inclusion and exclusion criteria and then 70 were reported 
in detail and included in the text.
Overall, our findings highlight the most recent advances in the field of host-pathogens interactions. We 
focused on the in vitro 3D modeling for the study of the microbial induced epithelial carcinogenesis 
and emphasized its ability in mimicking at best the role of bacteria and viruses within an in vivo 
microenvironment.
mICRObIOTa, ImmUNe RespONse aND epITHeLIaL CaNCeR
Several studies, among which that conducted by Kyrgiou et al.[10], underlined that vaginal microbiota 
may drastically inf luence host innate immune response, infection susceptibility and cervical cancer 
development, but without proving causality and thus making necessary further longitudinal studies. In 
this direction, Ilhan et al.[17], through a triple approach based on liquid chromatography mass spectrometry, 
16S rRNA gene sequencing and immunoassay, evaluated and integrated the metabolic signature of the 
vaginal microbiota and the inflammatory status changes of 78 women, including HPV-negative/positive 
controls, low-/high-grade cervical-dysplasia or -cancer affected females. These authors found that 
unique cervicovaginal metabolites and microbes allow to discriminate clearly the affected patients from 
healthy subjects, thus providing novel cancer hallmarks. For example, the lipidic three-hydroxy-butyrate, 
eicosenoate, and oleate/vaccenate are distinctive of cancer patients, while sphingolipids, plasmalogens and 
linoleate positively correlate with cervicovaginal inflammation. 
Regarding this niche, the absence of dysbiosis and a dominance of peculiar gram-positive bacteria belonging 
to the Lactobacillus genus may inhibit several pathogens, preserve aminoacidic and nucleotide metabolisms 
and avoid the inflammatory state. Conversely, Fusobacterium spp., F. nucleatum in primis, promotes cell 
survival, proliferation, dysregulated carcinogenesis and cervical cancer through the induction of the WNT/
Beta catenin signaling pathway, as emerged by research in colorectal cancer (CRC)[12,18,19]. 
Since it has been demonstrated a significant correlation between bacteria belonging to the Fusobacteria 
genus, mainly Sneathia sanguinegens, and high-grade squamous intraepithelial lesions, they could be hired 
as microbiological markers of clinically significant cervical diseases[10]. 
This evidence has also been observed in another study by Mitra et al.[12], who found that a relative 
abundance of Fusobacterium spp. associates with higher levels of cytokines such as IL-4 and TGF-1β, which 
have been shown to generate local immunosuppression, HPV immune evasion and cancer development.
Moreover F. nucleatum inversely correlates with CD3+-T cell counts, whose aberrant signaling and function 
is typical in cervical carcinogenesis. 
Al-Hebshi et al.[15] have reported an abundance of the periodontal pathogen F. nucleatum, selected by the 
tumor environment, followed to a lesser extent by Campylobacter, Parvimonas and Prevotella spp. in oral 
squamous cell carcinoma, while the Streptococci are frequently associated with a healthy status.
Although the results obtained from clinical studies vary in the oral cancer associated microbiota 
composition, partially due to differences in the methodological approaches, the functional data consistently 
show an enrichment of a virulent, chronic inflammatory bacteriota that, as a passenger within the tumor 
environment, contributes to the worsening of the tumoral disease. 
HIGH-RIsK HpVs, mICRObIOTa, epITHeLIaL meseNCHYmaL TRaNsITION aND CaNCeR 
pROGessION 
As known, EMT associates with cell migration, invasion, resistance to chemotherapy and anoikis. During 
this process, several signaling pathways, such as those involving TGF-β, Wnt, Hedgehog, β-catenin, Notch, 
Nanog, STAT3 and ERK, are activated in the cell leading to a pro-metastatic behavior[20,21]. In this context, 
EMT can be also regulated by HR-HPVs[22,23].
 
Despite anogenital and oropharyngeal squamous cell carcinomas (OPSCC) promoted by these viruses 
have a more favorable prognosis respect to HPV negative ones, EMT usually associates with an aggressive 
tumoral behavior, making HPV role an open issue. In a study on a cohort of 296 OPSCC-patients, EMT 
was confirmed as an adverse marker of evolution of HPV related carcinomas[24]. 
In another research, the expression of five EMT markers was assessed in normal and tumoral cervical 
tissues, revealing that E-cadherin and β-catenin expression decreases gradually, while that of N-cadherin, 
vimentin and fibronectin increases during malignant progression[25]. Moreover, Su et al.[26] studied the 
role of DNA methylation of the ten-eleven translocation methyl-cytosine dioxygenase 1 (TET1), which 
oxidizes 5-methylcytosine to 5-hydroxymethylcytosine within cervical lesions. At a precancerous level, 
TET1 inhibits EMT, interacting with chromatin modifiers and downregulating mesenchymal genes such 
as ZEB1 and VIM[26]. In vitro culture of cervical cancer cells revealed that p68, an ATP-dependent RNA 
helicase, induces EMT through the transcriptional activation of the TGF-β1 pathway, inducing cancer 
progression[27]. 
Finally, Pang et al.[28] reported that HPV18 E6 regulates YB-1 mRNA expression by promoting EMT and 
cervical lesion progression through the enhanced Snail expression. 
Moreover, both HPV and EMT upregulate programmed cell death ligand-1 (PD-L1) expression, an 
immune checkpoint and therapeutic target in OPSCC, whose efficacy is currently under investigation[29,30]. 
Precisely, PD-L1 is overexpressed in about half of OPSCC that seem to have a better response to anti-PD-1 
therapy[31]. 
Regarding the involvement of bacterial microbiota in EMT, F. nucleatum has been frequently found 
in stools and bioptic specimens of CRC affected patients, and more recently also of OPSCC patients. It 
has been suggested that this bacterium triggers EMT to malignant transformation by interacting with 
E-cadherin, as suggested by in vitro experiments on NCM460 cells[32,33]. In a cohort of stage III/IV CRC 
affected patients, Yan et al.[34] found a significant correlation between the presence of F. nucleatum and 
tumor progression also in relation to chemotherapy efficacy, suggesting its role as a biomarker for a 
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therapeutic approach improvement. Panebianco et al.[35] also confirmed this link. Moreover, the same 
authors underlined that not only gut bacteria, but also the intratumor ones, may inf luence patients’ 
response toward chemo- and immuno-therapeutic drugs and vice versa[36].
More recently, it has emerged that EMT can also be promoted by Porphyromonas gingivalis, an anaerobe 
frequently found in chronic periodontitis. In fact, it has been observed that this bacterium causes an 
early EMT of chronically infected human oral epithelial cells (OECs) that, through PI3K/Akt activation, 
ultimately lead to the loss of E-cadherin and to the accumulation of β-catenin, together with an increased 
expression of Zeb1, vimentin, MMP-2, -7, and -9. Moreover, upon stimulation with this bacterium, OECs 
migratory capacity increases proportionally[37-39]. 
Both F. nucleatum and P. gingivalis determine an enhanced transcription of mesenchymal markers, an 
increase of TGF-β1, TNF-α and EGF and a downregulation of those associated to epithelial layer integrity, 
as evidenced by transepithelial electrical resistance measures[40]. 
Recently, a new tumor metastasis model has been proposed. Till now it was supposed that epithelial-
like cancer cells acquire mesenchymal features in order to produce metastasis by exploiting the vascular 
system, and then switch back to an epithelial phenotype to establish the new tumor. The existence of 
a stable population of hybrid epithelial/mesenchymal cells, possessing epithelial and mesenchymal 
characteristics with both tumorigenic and metastatic properties, has been hypothesized[41,42]. Moreover, 
in predisposed individuals, with defects in the innate immunity response or with a specific epigenetic 
background, bacterial or viral infections could lead to EMT, causing a chronic inflammatory state, through 
the activation NF-kB and MAPK[43]. Considering this and the emerging role of the microbiota on EMT and 
cancer progression, more rational and shared laboratory models should be used to better investigate the 
microbiota composition[44] and its relationship with the human host.
IN VITRO epITHeLIaL mODeLs FOR sTUDYING THe HOsT-paTHOGeNs INTeRaCTIONs 
The first studies focused on host-pathogens connections started in the 1970s with Todaro[45] and Taylor-
Robinson[46], who described the interactions between oncogenic viruses and human cells, and mycoplasma 
pneumonia and ciliated tracheal epithelium, respectively. Since then, in vitro models acquired popularity 
in the microbiology field, due to their reproducibility, higher versatility and high-throughput data 
acquisition respect to in vivo models[47] [Table 1][5,16,38,45-62]. Undeniably, due to the improvement in imaging 
and screening techniques and to the in vitro models features, nowadays it is possible to directly analyse 
characteristics such as: specific surface-adhesion processes (i.e., biofilm formation), spreading capabilities, 
immune system escapes aptitudes, migration in 3D matrices, and host’s cell-type-specific interactions in 
general. 
The development of functional co-culture systems mostly depends on their ability to allow the physiological 
growth of cellular components in optimized culture media inside trans-well devices or microf luidic 
chambers. In this regard, Di Giulio et al.[50] developed a model in which Streptococcus mitis was grown with 
human gingival fibroblasts in saliva sterilized stocks enriched with 1% sucrose as culture medium. With 
this system, the authors demonstrated that S. mitis can penetrate within fibroblasts, via a FAK-integrin β1-
vinculin-actin mediated process, which is modulated by the saliva and the microenvironment themselves. 
Sterilized artificial saliva has also been used in more complex models such as the multi-culture trans-well 
system developed by Millhouse et al.[51], in which a complex multispecies biofilm, composed by S. mitis, F. 
nucleatum, P. gingivalis and Aggregatibacter actinomycetemcomitans, was grown on a glass slide and co-
cultivated in a trans-well together with immortalized oral keratinocytes (OKF6-TERT2). With this system, 
these authors validated the efficacy of commercially available oral hygiene products. 
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Despite these findings and the evidences on the cytoskeletal modifications, the impaired proliferation 
rate and the gene expression changes occurring in cells infected by bacterial or viral pathogens[50,63-66], 
some limitations arise when more complex evaluations are required. According to the literature, the 
microenvironment highly modifies cells behaviour; therefore, the lack of the “3D” in many in vitro models 
reduces the transferability potential of the in vitro data[52]. This is particularly true for epitheliotropic 
viruses, such as HPVs, for which the intracellular expression of viral proteins is conditioned by the 
epithelial renewal/stratification process that cannot be detected within 2D cultures.
In fact, most 3D models enable not only viral life cycle, but also virus induced cellular modifications. They 
are generally constituted by HPV infected keratinocytes, cultivated onto fibroblast repopulated matrices 
and let to stratify at the air-liquid interface in specific culture media. They can be easily analysed by 
western blot, histology, high throughput sequencing and protein-protein interaction assays. 
These models made possible to identify novel pro-oncogenic co-factors, such as p130[53] or 53BP1[5], 
important for investigating novel antiviral targets. 
3D RAFT (real architecture for 3D tissue) cultures also allowed to elucidate the effect of HPV chronic 
infection onto eukaryotic cells mitosis; as showed by Banerjee et al.[54], HPV DNA amplification occurs 
during host’s cell G2 phase, despite DNA eukaryotic amplification normally occurs in the S phase; in 
particular, they elucidated the key role of E7 in forcing host cells permanence in the G2 phase via cyclin B1 
cytoplasmic accumulation.
Table 1. Epithelial study models’ overview (images created with BioRender.com)
Epithelial study models Since Pros Cons Ref.
2D cultures 1920s In vitro  reproducibility; versatility; high-
throughput data acquisition
Inability to reproduce the in 
vivo  context; poor biological 
complexity; lack of the 3D; 
poor data reliability; no cell-cell 
interaction 
Todaro et al. [45]
Bergmann et al. [47]
In vivo  models 1980s Suitability for: (1) new therapies and 
preventative treatments testing; (2) 
biological processes understanding 
Inability to recapitulate the 
human tissue context; time-
consuming procedures; high 
costs; requirement of specific 
manual skills; ethical issues
Taylor-Robinson et al. [46]
Pasupuleti et al. [48]
3D spheroids 1980s-90s Fully humanized models; no animal 
sacrifice required
No tissue organization; 
unsatisfactory biological 
complexity; insufficient 
data reliability; lack of cell-
microenvironment interactions 
Melissaridou et al. [16]
Bergmann et al. [47]
Sawant et al. [61]
3D organotypic cultures 1990s-2000 Fully humanized models; no animal 
sacrifice required; capacity to mimic the 
in vivo  context: recapitulation of epithelial 
strata, cytokeratin differentiation, EMT 
markers expression and carcinogenic 
process; possibility of implementation 
with the vascular counterpart, 
macrophages and T-cells; permissiveness 
to the physiological growth of cellular 
components; appreciable biological 
complexity; suitability for the study of 
pathogen-induced cells modification and 
host tissue-microbial agents interactions; 
more reliability and cheaper to antiviral 
drugs properties study than xenografts; 
reliability of the data
Model management 
complexity; inability to mimic 
long-term conditions
Squarzanti et al. [5]
Sztukowska et al. [38]
Riedl et al. [49]
Di Giulio et al. [50]
Millhouse et al. [51]
Bradbury et al. [56]
Genovese et al. [53]
Banerjee et al. [54]
Chow et al. [55]
Spurgeon et al. [52]
Hogervorst et al. [57]
Fullar et al. [58]
de Carvalho Dias et al. [59]
Zhang et al. [60]
Dabija-Wolter et al. [62]
EMT: epithelial mesenchymal transition
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Additionally, RAFT cultures are a more reliable and cheaper solution to study antiviral drugs respect to 
xenografts in SCID mice, since they are more suitable to be analysed by in situ hybridization and RT-qPCR 
techniques[55]. 
Moreover, they can allow the study of host-virus interactions in absence of other cell types or tissues that 
could hide fundamental pathways promoted by the pathogen, especially when the studies require miRNA 
or EMT analysis. 
As previously described, HR-HPVs E6 and E7 proteins interact and inhibit host p53 and pRb onco-
suppressors respectively. Recently, the idea that E6 and E7 can also bind host miRNA or miRNA regulators 
has been evaluated[67]. Indeed, despite HPV inability to encode for miRNAs, HPV mediated indirect 
regulation of both onco-suppressive or tumorigenic miRNAs may offer the opportunity to identify novel 
therapeutic targets.
RaFT CULTRes, DRUG ResIsTaNCe aND emT ReseaRCH
Regarding drug resistance and EMT markers expression analysis, RAFT cultures can overcome both 2D 
and spheroid cultures limitations. Melissaridou et al.[16], working with 5 HNSCC-derived cell lines grown 
in both 2D and spheroids assays, observed that, while 2D eukaryotic cells and spheroid conformation 
changes the receptor topography and gene expression, and erases the drug resistance pathways that occur 
in vivo, 3D cultures can better mimic what happens during in vivo therapies and allow to study EMT 
expression markers such as CDH1, NANOG, SOX and EGFR. 
However, when epithelial models are necessarily to be used, spheroids utility is limited, because of the less 
reliability of the data they produce respect to those obtained with the organotypic models. In fact, although 
they are both made up of epithelial cells, spheroids morphology and structure are too much simplified 
and do not reproduce the mucosal epithelium in such a representative way as the 3D epithelial RAFTs do. 
Therefore, compared to 3D RAFTs, the spheroids are less performant for studies on the specific interactions 
that occur in a well-defined in vivo environment.
On the other hand, RAFT cultures can be built with both isolated healthy or tumour/cancer associated 
keratinocytes and fibroblasts, able to better elucidate the interactions between stromal and epithelial 
compartments that are at the basis of the initial steps of the carcinogenetic process[56]. Moreover, they 
recapitulate all the epithelial layers, the physiological cytokeratin differentiation and the carcinogenic 
process. 
By using in vitro reconstructed epithelial systems, Hogervorst et al.[57] highlighted the importance of the 
papillary-reticular fibroblasts switch. In fact, when epithelial cultures are grown in presence of switched 
fibroblasts, the expression of CAF associated markers (α-SMA and vimentin) and EMT markers (SNAIL2, 
N-cadherin and ZEB1) increase, thus suggesting that the fibroblasts switch could be considered an indicator 
of squamous cell carcinoma (SCC) progression. Similarly, Fullar et al.[58] proved that HPV16 induces the 
modification of connective matrix that, by the action of epithelial Matrix Metalloproteinase MMP-7 and 
fibroblast-produced MMP-2, loses collagen and fibronectin in favour of laminin, thus facilitating EMT and 
carcinogenic events. Comparable effects on MMP super-families were also observed in other HR-HPV 
positive models[68].
In agreement with the above, the last trend is to reproduce tissue models with the whole organ 
complexity[69]; in fact, the models have been implemented with the vascular component, with macrophages 
and T-cells, thus allowing to further improve the knowledge in the microbiology field[59-61].  
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In line with the technological progress, in the last few years several authors have focused their attention 
on the bacterial-induced EMT. For instance, Sztukowska et al.[38] showed that P. gingivalis, associated 
with OPSCC development, is able in a gingival 3D equivalent to induce the expression and the nuclear re-
localization of ZEB1, a well-known EMT transcriptional factor. This effect is reduced by the lack of the 
bacterial fimbrial FimA protein, while it is enhanced by the co-infection with F. nucleatum or S. gordonii. 
A similar study conducted by Lee et al.[37] showed that the carcinogenic properties of P. gingivalis are 
unrelated to the presence of chronic inflammation periodontitis. In this study, the authors showed that 
in addition to ZEB1, also glycogen synthase kinase-3 beta (p-GSK3β), Slug, Snail, and vimentin usually 
increase during EMT under the influence of P. gingivalis. Moreover, the co-infection with F. nucleatum 
induces the loss of adhesive molecules such as E-cadherin and β-catenin in cancer-committed cells and the 
overexpression of MMP-2, -7 and -9 as showed for HPV infection[69]. These findings confirm those obtained 
in an established periodontitis-associated oral tumorigenesis murine model used to demonstrate that both 
P. gingivalis and F. nucleatum induce tumorigenesis independently from the inf lammatory status[70]. In 
this latter study, the interaction of bacteria with the keratinocytes Toll-like receptor and the consequent 
activation of the IL-6-STAT3 axis was possibly involved in the tumorigenesis process. 
The above cellular models can be also used to quantify the microorganisms’ migration potential, as made 
by Dabija-Wolter et al.[62] who in vitro reconstructed a gingiva to evaluate the migration of F. nucleatum 
through a keratinized squamous epithelium without destroying it, while establishing a chronic infection 
[Figure 1].
Summarizing, in the last few years, thanks to their suitability to exceed the limitations of monolayer 
adherent cell cultures, as well as of in vivo models and spheroids, 3D epithelial co-cultures have become 
indispensable tools for investigating the interactions between microbial agents and their hosts. 
Figure 1. Schematic representation of SCC progression achievable by using in vitro  3D infected models. SCC: squamous cell carcinoma; 
HPV: human papillomavirus
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Although several questions are sti l l open, soon further improvements might help to generate 
microenvironments that also mimic the bacteria and virus migratory potential. 
CONCLUsION
Overall this review highlights the importance of the in vitro 3D modeling research field for the study of 
microbial induced epithelial carcinogenesis. Yet, further improvements are still needed to reach the level of 
complexity of the real tissue. These models will hopefully help to better understand the respective roles of 
virus and bacteria in HR-HPV-related cancers.
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